References
- Roden DM, Reele SB, Higgins SB, et al. Total suppression of ventricular arrhythmias by encainide: pharmacokinetic and electrocardiographic characteristics. N Engl J Med 1980:302:877–82
- Anderson JL, Mason JW, Winkle RA, et al. Clinical electrophysiologic effects of tocainide. Circulation 1978:57:685–91
- Winkle RA, Meffin PJ, Harrison DC. Long-term tocainide therapy for ventricular arrhythmias. Circulation 1978:57:1008–16
- Winkle RA, Meffin PJ, Fitzgerald JW, et al. Clinical efficacy and pharmacokinetics of a new orally effective antiarrhythmic, tocainide. Circulation 1976;54:885–9
- Leahey EB Jr, Bigger JT Jr. Mexiletine: a new antiarrhythmic drug. (Editorial) Ann Intern Med 1980;92:427–9
- Harper RW, Olsson SB. Effect of mexiletine on conduction of premature ventricular beats in man: a study using monophasic action potential recordings from the right ventricle. Cardiovasc Res 1979:13:311–9
- Danilo P Jr. Mexiletine. Am Heart J 1979:97:399–403
- Abinader EG, Cooper M. Mexiletine: use in control of chronic drug-resistant ventricular arrhythmia. JAMA 1979;242:337–9
- Cady WJ, Wilson CS, Chambers WA, et al. Mexiletine in the treatment of refractory ventricular arrhythmias: a report of five cases. Am Heart J 1980:99:181–4
- Wellens HJ, Tan SL, Bär FW, et al. Effect of verapamil studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia. Br Heart J 1977:39;1058–66
- Klein HO, Pauzner H, Di Segni E, et al. The beneficial effects of verapamil in chronic atrial fibrillation. Arch Intern Med 1979;139:747–9
- Hagemeijer F. Verapamil in the management of supraventricular tachyarrhythmias occurring after a recent myocardial infarction. Circulation 1978;57:751–5
- Mason JW, Winkle RA, Meffin PJ, et al. Electrophysiological effects of acebutolol. Br Heart J 1978:40:35–40
- Ahumada GG, Karlsberg RP, Jaffee AS, et al. Reduction of early ventricular arrhythmia by acebutolol in patients with acute myocardial infarction. Br Heart J 1979:41:654–9
- Aronow WS, Turbow M, Lurie M, et al. Treatment of premature ventricular complexes with acebutolol. Am J Cardiol 1979;43:106–8
- Gradman AH, Winkle RA, Fitzgerald JW, et al. Suppression of premature ventricular contractions by acebutolol. Circulation 1977:55:785–91
- Williams DO, Tatelbaum R, Most AS. Effective treatment of supraventricular arrhythmias with acebutolol. Am J Cardiol 1979:44:521–5
- Foster PR, King RM, Nicoll AB, et al. Suppression of ouabain-induced ventricular rhythms with aprindine HCl: a comparison with other antiarrhythmic agents. Circulation 1976:53:315–21
- Zipes DP, Troup PJ. New antiarrhythmic agents: amiodarone, aprindine, disopyramide, ethmozin, mexiletine. tocainide, verapamil. Am J Cardiol 1978:41:1005–24